The FY23 Defense Appropriations Act provides funding for the Pancreatic Cancer Research Program (PCARP) to support research of exceptional scientific merit and innovation with high impact that focuses on pancreatic cancer.
Society for Immunotherapy of Cancer is seeking the scientists to continue Steven A. Rosenberg’s legacy with a research award specifically for early career scientists focused on tackling challenges that face the field of immunology and cancer immunotherapy.
Harrington Discovery Institute at University Hospitals is now accepting letters of intent for the 2024 Harrington Scholar-Innovator Award for physician-scientists.
The FY23 Defense Appropriations Act provides funding for the Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research.
ACS has issued a request for applications for the Cancer Health Equity Research Centers grant.
The FY23 Defense Appropriations Act provides funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
The FY23 Defense Appropriations Act provides funding for the Pancreatic Cancer Research Program to support research of exceptional scientific merit and innovation with high impact that focuses on pancreatic cancer.
NCI and Cancer Research UK announced nine new research challenges aimed at tackling some of the most profound problems in cancer research. The global funding opportunity is part of the Cancer Grand Challenges program, an initiative launched by NCI and Cancer Research UK in 2020.
The FY23 Defense Appropriations Act provides funding for the Bone Marrow Failure Research Program to support innovative, high-impact bone marrow failure research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
The FY23 Defense Appropriations Act provides funding for the Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
